Navigation

Alcohol use disorders - clinical management

Alcohol-use disorders in adults and young people - clinical management

Status: History
Publication date: June 2010
Wave: 15
Process: CG
Notes:

NICE is developing three pieces of guidance relating to alcohol use disorders over the next two years. Each piece of guidance will focus on a different element of the care pathway, from the prevention and early identification of alcohol use disorders through to the clinical management of acute alcohol withdrawal and alcohol related liver disease and pancreatitis. The third piece of guidance will focus on the management of alcohol dependency and psychological interventions.

Because of the breadth of advice that will be covered and the short timescale in which NICE has to produce final recommendations, it will not be possible for one centre to develop all three pieces of guidance. Therefore, the topics have been allocated as follows:

Part 1 - Public health guidance

Alcohol use disorders in adults and young people: prevention and early identification (publication expected March 2010) - Centre for Public Health Excellence (CPHE) at NICE

Part 2 - Clinical guideline

Alcohol use disorders in adults and young people: clinical management (publication expected May 2010) - National Collaborating Centre for Chronic Conditions (NCC-CC)

Part 3 - Clinical guideline

Alcohol dependence and harmful alcohol use (publication expected January 2011) - National Collaborating Centre for Mental Health (NCC-MH)

NICE has set up a steering committee to oversee the production of these pieces of guidance.  This group, which will include development group members, staff from all three guidance-producing centres and senior NICE staff will identify and act on any gaps or overlaps across the different guidance topics in order to ensure that the final guidance produced is complementary and consistent.

As part of our normal process, NICE will set up independent guidance development groups, who will formulate recommendations. For clinical guidelines, members of the guideline development group (GDG) are multidisciplinary, comprising healthcare professionals, technical experts, and patients and/or carers. For public health programmes, members of the independent programme development group (PDG) are multidisciplinary, comprising healthcare professionals, technical experts, people working directly in public health, managers in the health service and other organisations. researchers and representatives from ‘lay' groups such as charities or patient/carer organisations.. As with all of our guidance, NICE ensures that members of the guidance development groups carry a breadth of experience and expertise across a range of settings and specialities so the development of recommendations reflects the broad nature of support required by people affected by alcohol dependence.

This page provides more detail on the Part 2 clinical guideline. Please follow the links above to view details of the other pieces of guidance.

Topic area:
  • Mental health and behavioural conditions
  • Public health
 

NICE project team

Centre for clinical practice lead: Christine Carson
Communications manager: Paul Cooney
Guidelines commissioning manager: Sarah Willet
Guidelines coordinator: Laura Bruton
Patient involvement lead: Victoria Thomas
Implementation lead: Katie Worrall
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Scoping workshop: 09 April 2008
Consultation on draft scope with stakeholders: 4 April - 2 May 2008
Consultation on draft guideline with stakeholders: 17 September – 12 November 2009
Pre-publication check: 15 March 2010
Publication date: June 2010
Top


 

Project history

Date Update
31 August 2007 The remit was received from the Department of Health and the Welsh Assembly Government in April as part of the Institute's 15th wave work programme.
4 April 2008 The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations, by the deadline shown.
12 August 2008

The scope defines what aspects of care are covered by the guideline and to whom it applies.

Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.

23 January 2009

The Guideline Development Group (GDG) oversees the development process. A list of GDG members is available on this page.

The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. 

Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline.  Please see timescales on this page for dates of consultation with stakeholders.

1 April 2009 Responsibility for the development of this guideline has transferred to the National Clinical Guidelines Centre. Key contacts and timelines remain unchanged.
17 September 2009 The consultation draft of the guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations, by the deadline shown.
Top


 

Key documents

This page was last updated: 02 June 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.